Vaccination

Five things you need to know about: mRNA vaccine safety

The world's first mRNA vaccine has begun its rollout after being produced at unprecedented speed as part of the global effort to end the COVID-19 pandemic. A second one is hot on its heels. The two—one made by Pfizer/BioNTech ...

Medical research

Messenger RNA: How a long shot idea led to COVID-19 vaccines

Hungarian-born scientist Katalin Kariko's obsession with researching a substance called mRNA to fight disease once cost her a faculty position at a prestigious US university, which dismissed the idea as a dead end.

Diseases, Conditions, Syndromes

Risk for Guillain-Barré syndrome up after Ad.26.COV2.S vaccination

The incidence of Guillain-Barré syndrome (GBS) is increased after Ad.26.COV2.S vaccination, but incidence is not increased after mRNA vaccination, according to a study published online April 26 in JAMA Network Open.

Vaccination

Optimization of mRNA containing nanoparticles

The research neutron source Hein Maier-Leibnitz (FRM II) at the Technical University of Munich (TUM) is playing an important role in the investigation of mRNA nanoparticles similar to the ones used in the COVID-19 vaccines ...

page 1 from 32